Key result
Stenting CRMD lead-associated central vein stenosis yields ~100% procedural success but poor long-term patency.
Why the study?
Symptomatic central vein stenosis commonly occurs with CRMD leads ipsilateral to AV hemodialysis access, and outcomes after stenting in this setting are not well defined.
Does stenting improve patency and maintain device function in hemodialysis patients with CRMD lead-associated central vein stenosis?
Population
14 hemodialysis patients with AV access and ipsilateral CRMD with symptomatic central vein stenosis or occlusion
Comparison
Stenting after inadequate response to angioplasty
Design
Retrospective observational study
Follow-up
12 months
Authors
Loading...
Stenting appears safe with high procedural success; leaves open durability and comparative efficacy versus alternatives in hemodialysis patients.
Observational (n=14)
Does stenting improve patency and maintain device function in hemodialysis patients with CRMD lead-associated central vein stenosis?
Stenting for CRMD lead-associated central vein stenosis in hemodialysis patients is safe, yields high procedural success, and does not impair CRMD function, though repeat interventions are often needed to maintain patency.
Saad et al. (2010) conducted an observational in Central vein stenosis or occlusion associated with cardiac rhythm management device leads (n=14). Stenting was evaluated on Procedural success. Stenting for CRMD lead-associated central vein stenosis achieved 100% procedural success and no complications, with primary patency rates of 45.5% at 6 months and 9.0% at 12 months.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: